You are currently viewing the summary.
See the full text- Join / Subscribe
- Buy article
- member account Enable
- Renew subscription
- Recommend a subscription to your library
- Help for librarians
Summary
Fifteen years after learning about the medical benefits of cannabis from patients in a clinic for sickle cell disease in Kingston, Mark Ware studied the drug on a large scale. A pain management researcher at McGill University Health Centre in Montreal, Canada, he directed the registry Cannabis Quebec, a new one-of-a-kind database that collects information about each prescribed marijuana patient the province over the next 10 years -an estimated 3,000 in all. By collecting data on symptoms, dosage, improvement, and side effects, registry, launched on 11 May and funded by a consortium of nonprofit grant from Canada for the cannabinoid research, aims to fill gaps in knowledge about the effectiveness and safety of medical marijuana treatment. Although more and more states and countries legalize pot for medical purposes, clinical trials of smoked cannabis are rare. "Decisions [about medical marijuana] are made at the ballot box rather than in laboratories," said Raul Gonzalez, a psychologist at Florida International University in Miami, who studies the cognitive effects of cannabis use in HIV patients / AIDS.
-
↵ * in Montreal Canada
0 Komentar